451 related articles for article (PubMed ID: 17113254)
41. Short interfering RNA against transient receptor potential vanilloid 1 attenuates cisplatin-induced hearing loss in the rat.
Mukherjea D; Jajoo S; Whitworth C; Bunch JR; Turner JG; Rybak LP; Ramkumar V
J Neurosci; 2008 Dec; 28(49):13056-65. PubMed ID: 19052196
[TBL] [Abstract][Full Text] [Related]
42. Dose-dependent effect of 8-day cisplatin administration upon the morphology of the albino guinea pig cochlea.
Cardinaal RM; de Groot JC; Huizing EH; Veldman JE; Smoorenburg GF
Hear Res; 2000 Jun; 144(1-2):135-46. PubMed ID: 10831872
[TBL] [Abstract][Full Text] [Related]
43. Cochlear protection against cisplatin by viral transfection of X-linked inhibitor of apoptosis protein across round window membrane.
Jie H; Tao S; Liu L; Xia L; Charko A; Yu Z; Bance M; Yin S; Robertson GS; Wang J
Gene Ther; 2015 Jul; 22(7):546-52. PubMed ID: 25809464
[TBL] [Abstract][Full Text] [Related]
44. Application of antioxidants and other agents to prevent cisplatin ototoxicity.
Rybak LP; Whitworth C; Somani S
Laryngoscope; 1999 Nov; 109(11):1740-4. PubMed ID: 10569399
[TBL] [Abstract][Full Text] [Related]
45. Ototoxicity: mechanisms of cochlear impairment and its prevention.
Tabuchi K; Nishimura B; Nakamagoe M; Hayashi K; Nakayama M; Hara A
Curr Med Chem; 2011; 18(31):4866-71. PubMed ID: 21919841
[TBL] [Abstract][Full Text] [Related]
46. The protective effects of whortleberry extract against cisplatin-induced ototoxicity in rats.
Özdemir D; Özgür A; Kalkan Y; Terzi S; Tümkaya L; Yılmaz A; Çeliker M; Dursun E
Braz J Otorhinolaryngol; 2019; 85(1):55-62. PubMed ID: 29174583
[TBL] [Abstract][Full Text] [Related]
47. A combinatorial approach to protect sensory tissue against cisplatin-induced ototoxicity.
Febles NK; Bauer MA; Ding B; Zhu X; Gallant ND; Frisina RD
Hear Res; 2022 Mar; 415():108430. PubMed ID: 35051751
[TBL] [Abstract][Full Text] [Related]
48. Assessing cisplatin-induced ototoxicity and otoprotection in whole organ culture of the mouse inner ear in simulated microgravity.
Tropitzsch A; Arnold H; Bassiouni M; Müller A; Eckhard A; Müller M; Löwenheim H
Toxicol Lett; 2014 Jun; 227(3):203-12. PubMed ID: 24709139
[TBL] [Abstract][Full Text] [Related]
49. WR-2721 (Amifostine) ameliorates cisplatin-induced hearing loss but causes neurotoxicity in hamsters: dose-dependent effects.
Church MW; Blakley BW; Burgio DL; Gupta AK
J Assoc Res Otolaryngol; 2004 Sep; 5(3):227-37. PubMed ID: 15185124
[TBL] [Abstract][Full Text] [Related]
50. Apelin-13 protects against cisplatin-induced ototoxicity by inhibiting apoptosis and regulating STAT1 and STAT3.
Yin H; Sun Y; Ya B; Guo Y; Zhao H; Zhang L; Wang F; Zhang W; Yang Q
Arch Toxicol; 2023 Sep; 97(9):2477-2493. PubMed ID: 37395757
[TBL] [Abstract][Full Text] [Related]
51. Comparative ototoxicity of cisplatin during acute and chronic treatment.
Saito T; Aran JM
ORL J Otorhinolaryngol Relat Spec; 1994; 56(6):315-20. PubMed ID: 7838482
[TBL] [Abstract][Full Text] [Related]
52. Nitric oxide synthase inhibitor reduces the apoptotic change in the cisplatin-treated cochlea of guinea pigs.
Watanabe K; Hess A; Michel O; Yagi T
Anticancer Drugs; 2000 Oct; 11(9):731-5. PubMed ID: 11129736
[TBL] [Abstract][Full Text] [Related]
53. The role of peroxiredoxin I in cisplatin-induced ototoxicity.
Le Q; Tabuchi K; Warabi E; Hara A
Auris Nasus Larynx; 2017 Apr; 44(2):205-212. PubMed ID: 27318370
[TBL] [Abstract][Full Text] [Related]
54. Cisplatin-induced ototoxicity: transporters playing a role in cisplatin toxicity.
Waissbluth S; Daniel SJ
Hear Res; 2013 May; 299():37-45. PubMed ID: 23467171
[TBL] [Abstract][Full Text] [Related]
55. Taurine attenuates aminoglycoside ototoxicity by inhibiting inducible nitric oxide synthase expression in the cochlea.
Liu HY; Chi FL; Gao WY
Neuroreport; 2008 Jan; 19(1):117-20. PubMed ID: 18281904
[TBL] [Abstract][Full Text] [Related]
56. Lovastatin protects against cisplatin-induced hearing loss in mice.
Fernandez K; Spielbauer KK; Rusheen A; Wang L; Baker TG; Eyles S; Cunningham LL
Hear Res; 2020 Apr; 389():107905. PubMed ID: 32062294
[TBL] [Abstract][Full Text] [Related]
57. Alterations in the stria vascularis in relation to cisplatin ototoxicity and recovery.
Sluyter S; Klis SF; de Groot JC; Smoorenburg GF
Hear Res; 2003 Nov; 185(1-2):49-56. PubMed ID: 14599692
[TBL] [Abstract][Full Text] [Related]
58. AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity.
Cooper LB; Chan DK; Roediger FC; Shaffer BR; Fraser JF; Musatov S; Selesnick SH; Kaplitt MG
Otol Neurotol; 2006 Jun; 27(4):484-90. PubMed ID: 16791039
[TBL] [Abstract][Full Text] [Related]
59. Astragalosides reduce cisplatin ototoxicity in guinea pigs.
Xiong M; He Q; Wang J; Lai H
ORL J Otorhinolaryngol Relat Spec; 2011; 73(3):131-6. PubMed ID: 21494054
[TBL] [Abstract][Full Text] [Related]
60. Mechanisms of cisplatin ototoxicity and progress in otoprotection.
Rybak LP
Curr Opin Otolaryngol Head Neck Surg; 2007 Oct; 15(5):364-9. PubMed ID: 17823555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
